KYVERNA THERAPEUTICS, INC.

Lobbying client · California · filed 2026 to 2026

Biopharmaceutical company

$80,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (72192), not by name.

Firms hired 1

BROWNSTEIN HYATT FARBER SCHRECK, LLP $80,000 3 filings

Reported by year 1 year

2026 $80,000 3 filings

Issues lobbied 2

Pharmacy 2
Health Issues 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Food & Drug Administration (FDA) 1
Health & Human Services, Dept of (HHS) 1
Office of Management & Budget (OMB) 1
White House Office 1

Recent filings 3 total

Q2

BROWNSTEIN HYATT FARBER SCHRECK, LLP

2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 17, 2026

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP

1st Quarter (Jan 1 - Mar 31) 2026 · $20,000 income · posted Apr 19, 2026

View → RR

BROWNSTEIN HYATT FARBER SCHRECK, LLP

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 3, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.